From the 30-year follow-up of the longest running prostate cancer screening trial, to smarter ways to use MRI in screening and understanding the psychological impact on patients - research presented at the EAU Congress in London this weekend will show just how far our knowledge around prostate cancer screening has come.

A new clinic-ready web-based risk prediction tool is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes. 

A Simon Fraser University study is pushing back against the “easy narrative” that not getting vaccinated is entirely a personal decision.

Rather, vaccine hesitancy in Canada comes down to significant cultural, administrative, institutional and governance barrers that reinforce mistrust and create inequitable access to vaccines, say SFU researchers. 

Wearable devices and digital apps that are available to consumers are emerging as potential tools in neurological care. These include smart watches and fitness trackers to monitor heart rate, physical activity, sleep and other health factors. To provide neurologists with guidance on the use, limitations and evidence on non-U.S. Food & Drug Administration (FDA)-cleared wearable technology, the American Academy of Neurology has developed an Emerging Issues in Neurology article published March 11, 2026, in Neurology^®, the medical journal of the American Academy of Neurology.